Vitamin C and the amino acid lysine are effective at preventing and reversing heart disease when taken at high doses. Linus Pauling and Matthias Rath developed a theory that the underlying cause of heart disease is a vitamin C deficiency called chronic scurvy. This leads to the production of Lp(a) cholesterol, which causes atherosclerotic plaques to form on artery walls. Pauling and Rath showed that high doses of vitamin C and lysine act as Lp(a) inhibitors, preventing it from binding to arteries and destroying existing plaques. Clinical trials supported that taking 3,000-18,000 mg of vitamin C and 3,000-6,000 mg of lysine daily can cure
This document discusses potassium levels in the blood and factors that can cause hypokalemia (low potassium) or hyperkalemia (high potassium). It begins by stating the normal range for potassium in blood is 3.5-5 mEq/L. It then provides multiple potential causes for abnormal potassium levels including medications, diet, vomiting/diarrhea, kidney disease, and cellular shifts of potassium between extracellular and intracellular fluid. Mnemonics are also presented to help remember key points. Assessment findings and complications associated with hypo- and hyperkalemia like arrhythmias and muscle weakness are described.
This document discusses the approach to hypokalemia, including its definition, prevalence, physiology, causes, symptoms, diagnosis, and treatment. Hypokalemia is defined as a plasma potassium level below 3.5 mEq/L and can range from mild to severe. It affects around 14% of outpatients and is more common in hospitalized patients. Potassium levels are tightly regulated and most potassium is found intracellularly. Causes of hypokalemia include low intake, redistribution into cells, and increased loss due to renal or extra-renal factors. Clinical symptoms depend on severity and may include fatigue, weakness, constipation or arrhythmias. Treatment involves replacing potassium stores orally or intravenously
This document discusses the approach to hypokalemia. It begins by covering the pathophysiology of potassium homeostasis and how small changes in potassium levels can have profound effects. It then discusses factors that can modify cellular potassium distribution like acid-base status, hormones, exercise and more. Treatment of hypokalemia involves decreasing potassium losses, replenishing stores, addressing any toxicities, and determining the underlying cause. Oral and intravenous potassium replacement is discussed as well as monitoring requirements and administration rates.
Disorders Of Sodium And Potassium Metabolismraj kumar
This document discusses disorders of sodium and potassium metabolism. It outlines the major mediators that regulate sodium and water balance, including the renin-angiotensin-aldosterone axis and antidiuretic hormone. It then reviews the etiologies and pathophysiology of abnormalities in potassium and sodium balance, including hyperkalemia, hypokalemia, hyponatremia, and hypernatremia. Finally, it presents four case studies as examples.
Congestive heart failure occurs when the heart cannot pump enough blood to meet the body's needs. It is caused by problems with factors that determine cardiac performance like preload, afterload, contractility, and heart rate. Common treatments aim to reduce symptoms by decreasing preload and afterload through drugs like ACE inhibitors, beta blockers, diuretics, and vasodilators. Digoxin and other inotropic drugs are used to improve contractility but have side effects risking toxicity. Managing comorbidities, sodium intake, and activity levels also helps treatment.
Hypokalemia, or low potassium levels, can have significant effects on muscles, the cardiovascular and nervous systems. It is defined as a potassium level below 3.5 mEq/L. The majority of potassium is found inside cells and is essential for various cellular functions through membrane pumps and channels. Causes of hypokalemia include reduced intake, redistribution into cells, and increased losses through the kidneys or gastrointestinal tract. Treatment focuses on replacing potassium stores through oral or intravenous supplementation, addressing the underlying cause, and preventing further losses and complications like cardiac arrhythmias.
The document discusses various topics related to fluid and electrolyte management including:
1. Types of dehydration (isonatremic, hyponatremic, hypernatremic) and how to correct each over 24-48 hours depending on the sodium level and rate of correction.
2. Common IV fluid solutions and their electrolyte content.
3. Causes and management of hyperkalemia and hypokalemia including calcium, sodium bicarbonate, dextrose+insulin, and beta-agonists.
4. Definition and characteristics of SIADH (syndrome of inappropriate antidiuretic hormone secretion) as a cause of euvolemic hyponat
Sb wh tn jk vit c quantum presentation1Shelby Burns
This document summarizes research optimizing vitamin C's function as a cofactor in collagen synthesis using density functional theory (DFT). Key points:
- Vitamin C is required for collagen synthesis, which forms 25-35% of human body protein. DFT was used to model how vitamin C binds in an enzyme involved in collagen formation.
- Different basis sets (cc-PVTZ, cc-PVDZ, 6-31G) and functionals (B3LYP, BPV86, LSDA) were tested to optimize vitamin C's structure and binding.
- Results show vitamin C binding interactions with amino acids in the enzyme active site, with average hydrogen bond and van der
This document discusses potassium levels in the blood and factors that can cause hypokalemia (low potassium) or hyperkalemia (high potassium). It begins by stating the normal range for potassium in blood is 3.5-5 mEq/L. It then provides multiple potential causes for abnormal potassium levels including medications, diet, vomiting/diarrhea, kidney disease, and cellular shifts of potassium between extracellular and intracellular fluid. Mnemonics are also presented to help remember key points. Assessment findings and complications associated with hypo- and hyperkalemia like arrhythmias and muscle weakness are described.
This document discusses the approach to hypokalemia, including its definition, prevalence, physiology, causes, symptoms, diagnosis, and treatment. Hypokalemia is defined as a plasma potassium level below 3.5 mEq/L and can range from mild to severe. It affects around 14% of outpatients and is more common in hospitalized patients. Potassium levels are tightly regulated and most potassium is found intracellularly. Causes of hypokalemia include low intake, redistribution into cells, and increased loss due to renal or extra-renal factors. Clinical symptoms depend on severity and may include fatigue, weakness, constipation or arrhythmias. Treatment involves replacing potassium stores orally or intravenously
This document discusses the approach to hypokalemia. It begins by covering the pathophysiology of potassium homeostasis and how small changes in potassium levels can have profound effects. It then discusses factors that can modify cellular potassium distribution like acid-base status, hormones, exercise and more. Treatment of hypokalemia involves decreasing potassium losses, replenishing stores, addressing any toxicities, and determining the underlying cause. Oral and intravenous potassium replacement is discussed as well as monitoring requirements and administration rates.
Disorders Of Sodium And Potassium Metabolismraj kumar
This document discusses disorders of sodium and potassium metabolism. It outlines the major mediators that regulate sodium and water balance, including the renin-angiotensin-aldosterone axis and antidiuretic hormone. It then reviews the etiologies and pathophysiology of abnormalities in potassium and sodium balance, including hyperkalemia, hypokalemia, hyponatremia, and hypernatremia. Finally, it presents four case studies as examples.
Congestive heart failure occurs when the heart cannot pump enough blood to meet the body's needs. It is caused by problems with factors that determine cardiac performance like preload, afterload, contractility, and heart rate. Common treatments aim to reduce symptoms by decreasing preload and afterload through drugs like ACE inhibitors, beta blockers, diuretics, and vasodilators. Digoxin and other inotropic drugs are used to improve contractility but have side effects risking toxicity. Managing comorbidities, sodium intake, and activity levels also helps treatment.
Hypokalemia, or low potassium levels, can have significant effects on muscles, the cardiovascular and nervous systems. It is defined as a potassium level below 3.5 mEq/L. The majority of potassium is found inside cells and is essential for various cellular functions through membrane pumps and channels. Causes of hypokalemia include reduced intake, redistribution into cells, and increased losses through the kidneys or gastrointestinal tract. Treatment focuses on replacing potassium stores through oral or intravenous supplementation, addressing the underlying cause, and preventing further losses and complications like cardiac arrhythmias.
The document discusses various topics related to fluid and electrolyte management including:
1. Types of dehydration (isonatremic, hyponatremic, hypernatremic) and how to correct each over 24-48 hours depending on the sodium level and rate of correction.
2. Common IV fluid solutions and their electrolyte content.
3. Causes and management of hyperkalemia and hypokalemia including calcium, sodium bicarbonate, dextrose+insulin, and beta-agonists.
4. Definition and characteristics of SIADH (syndrome of inappropriate antidiuretic hormone secretion) as a cause of euvolemic hyponat
Sb wh tn jk vit c quantum presentation1Shelby Burns
This document summarizes research optimizing vitamin C's function as a cofactor in collagen synthesis using density functional theory (DFT). Key points:
- Vitamin C is required for collagen synthesis, which forms 25-35% of human body protein. DFT was used to model how vitamin C binds in an enzyme involved in collagen formation.
- Different basis sets (cc-PVTZ, cc-PVDZ, 6-31G) and functionals (B3LYP, BPV86, LSDA) were tested to optimize vitamin C's structure and binding.
- Results show vitamin C binding interactions with amino acids in the enzyme active site, with average hydrogen bond and van der
Guidelines for Good Management of DiabetesTri Tolonen
Application of the advice given by this guide helps the diabetic treat him or herself so that minimal or no medication should be needed. Changing the life style for the better can reduce the risk of complications and slow down their development.
Hypertension, also known as high blood pressure, is a long-term medical condition in which the blood pressure in the arteries is persistently elevated. Essential hypertension is the most common type of high blood pressure, accounting for 90-95% of cases, where the cause is unknown. Left untreated, hypertension can increase the risks of heart disease and stroke, two of the leading causes of death globally.
This document discusses the role of nutraceuticals in cardiovascular diseases. It begins by defining cardiovascular diseases and describing the process of atherosclerosis. It then discusses various cardiovascular diseases and risk factors. The document outlines some prominent markers for vascular disease and explains what nutraceuticals are. It describes the "nutraceutical triple play" approach for preventing and reversing vascular disease. Finally, it provides specific examples of nutraceuticals like sterols, teas, fibers, fats, tocotrienols, vitamin D, and pantethine and their roles in reducing cardiovascular risk.
- Cardiovascular disease is the leading cause of death in the world and United States, with over 80 million American adults affected by some form of cardiovascular disease such as high blood pressure, heart attack, coronary artery disease, or stroke.
- Cardiovascular disease often progresses silently for decades before symptoms appear, with over 50% of people experiencing their first symptom as a heart attack or stroke.
- Key factors in cardiovascular disease development include high blood pressure, atherosclerosis, and arteriosclerosis which involve the buildup of plaque and thickening of the artery walls over time. Maintaining nitric oxide levels through supplementation with L-arginine may help prevent and reverse this progression.
Atherosclerosis and myocardial infarctionautumnpianist
This document defines atherosclerosis as the hardening and loss of elasticity of arteries due to plaque buildup. It also defines myocardial infarction as irreversible necrosis of heart muscle due to prolonged ischemia. It then proceeds to explain the process of atherosclerosis, from initial endothelial injury to formation of plaque and potential blockage. For myocardial infarction, it notes that ischemia beyond a critical threshold can cause heart muscle cell death. Causes discussed include presence of atherosclerosis and high lipoprotein(a) levels.
Ranolazine is a novel anti-anginal drug that selectively inhibits the late inward sodium current in cardiac cells, reducing calcium overload during ischemia. It improves exercise tolerance and reduces angina symptoms and nitroglycerin use when added to standard anti-anginal therapies. Clinical trials demonstrate ranolazine's efficacy in reducing angina frequency and improving exercise performance without affecting heart rate or blood pressure. When added to amlodipine, ranolazine further reduced angina and nitroglycerin use.
http://www.lotusholisticmedicine.com - Integrated holistic approach to treat body, mind and soul. We adopt goodness of modern conventional medicine, ancient herbal medicine (SIDDHA), to activate innate healing potential by naturopathy and yoga therapy and energize the mind and soul with positive promotion of mental well being and by incorporating spirituality for self healing.
Tako-Tsubo cardiomyopathy, also known as broken heart syndrome, is caused by a sudden surge in stress hormones that can temporarily weaken the heart muscle. It most often affects post-menopausal women after experiencing severe emotional or physical stress. The condition is characterized by abnormal widening of the left ventricle and reduced pumping ability. While symptoms may mimic a heart attack, diagnostic testing shows no blockages in the coronary arteries. Management focuses on supportive care with medications until the heart muscle regains its normal function within weeks. Prognosis is generally good, though heart failure can occur in some cases.
Tako-Tsubo cardiomyopathy, also known as broken heart syndrome, is a temporary heart condition brought on by sudden intense emotions or physical stress. It causes the left ventricle of the heart to balloon out at the bottom and not pump properly. The condition is usually triggered by surges of stress hormones like epinephrine and norepinephrine. While it resembles a heart attack, angiography shows no blockages in the coronary arteries. Symptoms include chest pain and shortness of breath. Treatment focuses on supporting heart function with medications until the heart recovers on its own, which usually occurs within weeks.
An acute myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow to the heart is blocked, injuring the heart muscle. Risk factors include previous cardiovascular disease, older age, smoking, high cholesterol, diabetes, high blood pressure, obesity, and chronic kidney disease. Treatment involves restoring blood flow through procedures like angioplasty or thrombolysis, along with medications like aspirin, nitroglycerin, and statins. Recovery involves cardiac rehabilitation with exercise training and lifestyle changes to manage risk factors and prevent future heart attacks.
The document discusses several topics related to health and medicine science news:
- A chaperone enzyme was identified as a new potential target for cancer treatments.
- A gene variant that protects some African Americans from coronary artery disease was discovered.
- The rest of the document provides background information on cancer, coronary heart disease, their causes and risk factors, and current medical treatments.
Lipoproteins are biochemical assemblies containing both lipids and proteins that enable fats like triglycerides and cholesterol to be transported around the body in the bloodstream. Examples include HDL and LDL lipoproteins. Atherosclerosis is a disease where plaque builds up in the arteries due to factors like high cholesterol, reducing blood flow and potentially leading to heart attack, stroke or other issues if left untreated. Treatments for atherosclerosis focus on lifestyle changes and medications to control risk factors and cholesterol levels, or procedures like angioplasty or endarterectomy in severe cases.
Coronary artery disease (CAD) occurs when the coronary arteries become narrowed or blocked, limiting blood flow to the heart. A seminar on CAD covered its definition, causes like smoking and high cholesterol, symptoms like chest pain, diagnostic tests, and management. CAD develops over many years as plaques build up in the arteries. It is the most common cause of death globally.
This document summarizes research on vitamin D deficiency and cardiovascular risks. It discusses how vitamin D metabolism and mechanisms of action may impact cardiovascular outcomes. Several studies are cited showing associations between vitamin D deficiency and increased risks of hypertension, diabetes, heart disease, and mortality. However, the document also notes controversies in the research and calls for more rigorous randomized controlled trials. It outlines objectives and methods for a study examining vitamin D levels in patients with ischemic heart disease. The conclusion is that vitamin D levels correlate with cardiovascular disease and supplementation may help outcomes, but more clinical trials are still needed.
A 70-year-old female with a long history of uncontrolled hypertension was admitted for acute heart failure. On examination, she was in severe respiratory distress and orthopnea. Imaging showed severe calcified coarctation of the aorta, bicuspid aortic valve with severe stenosis, and significant coronary artery disease. An interventional cardiology team decided to perform a two-stage endovascular procedure to repair the cardiac and vascular issues due to her multiple comorbidities.
Potassium is a mineral important for many bodily functions like muscle contractions and regulating heartbeat. It is found in foods like fruits, vegetables, nuts, and whole grains. A potassium deficiency can cause muscle cramps, congestive heart failure, diarrhea, and other conditions. It is important to get adequate potassium through diet or supplements.
This document discusses cardiovascular drugs and their uses. It begins by defining cardiovascular drugs as those that act on the heart or blood vessels. It then describes the anatomy of the heart including the myocardium, conduction system, and nerve supply. It lists some common cardiovascular conditions treated by drugs such as congestive heart failure, angina pectoris, cardiac arrhythmias, and hypertension. For each condition, it provides details on symptoms, types, and mechanisms of treatment with drugs. It also discusses the mechanisms of several classes of cardiovascular drugs including cardiac glycosides, calcium channel blockers, beta blockers, and others.
Systemic lupus erythematosus (SLE) can involve all layers of the heart, including the pericardium, myocardium, valves, and coronary arteries. Patients with SLE have a 4-8 fold increased risk of developing cardiovascular disease compared to the general population. Studies have found significantly higher rates of atherosclerosis in SLE patients compared to age-matched controls, even in younger patients and those without traditional risk factors. Aggressive treatment of modifiable risk factors such as dyslipidemia, hypertension, and smoking is important for reducing cardiovascular risk in SLE patients.
Chelation therapy involves injecting or orally taking the synthetic amino acid EDTA, which binds to heavy metals like lead and calcium in the blood. This process releases hydrogen atoms that attach to arterial plaques, making the plaques soluble so they can be excreted in urine. As a result, arterial walls become softer and blood flow increases to organs. Some studies show chelation therapy may help unclog arteries and improve heart health, but more research is still needed due to potential side effects like hypocalcemia and zinc depletion.
The document discusses cardiovascular disease (CVD), which includes heart disease and stroke. CVD is the UK's number one killer. It occurs when fatty deposits build up in the arteries, restricting blood flow and oxygen to the heart and brain. A plant-based diet can help prevent and treat CVD in several ways. It is lower in saturated fat and cholesterol than the standard Western diet, and higher in nutrients that support heart health. Factors like high blood pressure, high cholesterol levels, obesity, and smoking increase CVD risk, but following a plant-based diet can help regulate these risk factors.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Guidelines for Good Management of DiabetesTri Tolonen
Application of the advice given by this guide helps the diabetic treat him or herself so that minimal or no medication should be needed. Changing the life style for the better can reduce the risk of complications and slow down their development.
Hypertension, also known as high blood pressure, is a long-term medical condition in which the blood pressure in the arteries is persistently elevated. Essential hypertension is the most common type of high blood pressure, accounting for 90-95% of cases, where the cause is unknown. Left untreated, hypertension can increase the risks of heart disease and stroke, two of the leading causes of death globally.
This document discusses the role of nutraceuticals in cardiovascular diseases. It begins by defining cardiovascular diseases and describing the process of atherosclerosis. It then discusses various cardiovascular diseases and risk factors. The document outlines some prominent markers for vascular disease and explains what nutraceuticals are. It describes the "nutraceutical triple play" approach for preventing and reversing vascular disease. Finally, it provides specific examples of nutraceuticals like sterols, teas, fibers, fats, tocotrienols, vitamin D, and pantethine and their roles in reducing cardiovascular risk.
- Cardiovascular disease is the leading cause of death in the world and United States, with over 80 million American adults affected by some form of cardiovascular disease such as high blood pressure, heart attack, coronary artery disease, or stroke.
- Cardiovascular disease often progresses silently for decades before symptoms appear, with over 50% of people experiencing their first symptom as a heart attack or stroke.
- Key factors in cardiovascular disease development include high blood pressure, atherosclerosis, and arteriosclerosis which involve the buildup of plaque and thickening of the artery walls over time. Maintaining nitric oxide levels through supplementation with L-arginine may help prevent and reverse this progression.
Atherosclerosis and myocardial infarctionautumnpianist
This document defines atherosclerosis as the hardening and loss of elasticity of arteries due to plaque buildup. It also defines myocardial infarction as irreversible necrosis of heart muscle due to prolonged ischemia. It then proceeds to explain the process of atherosclerosis, from initial endothelial injury to formation of plaque and potential blockage. For myocardial infarction, it notes that ischemia beyond a critical threshold can cause heart muscle cell death. Causes discussed include presence of atherosclerosis and high lipoprotein(a) levels.
Ranolazine is a novel anti-anginal drug that selectively inhibits the late inward sodium current in cardiac cells, reducing calcium overload during ischemia. It improves exercise tolerance and reduces angina symptoms and nitroglycerin use when added to standard anti-anginal therapies. Clinical trials demonstrate ranolazine's efficacy in reducing angina frequency and improving exercise performance without affecting heart rate or blood pressure. When added to amlodipine, ranolazine further reduced angina and nitroglycerin use.
http://www.lotusholisticmedicine.com - Integrated holistic approach to treat body, mind and soul. We adopt goodness of modern conventional medicine, ancient herbal medicine (SIDDHA), to activate innate healing potential by naturopathy and yoga therapy and energize the mind and soul with positive promotion of mental well being and by incorporating spirituality for self healing.
Tako-Tsubo cardiomyopathy, also known as broken heart syndrome, is caused by a sudden surge in stress hormones that can temporarily weaken the heart muscle. It most often affects post-menopausal women after experiencing severe emotional or physical stress. The condition is characterized by abnormal widening of the left ventricle and reduced pumping ability. While symptoms may mimic a heart attack, diagnostic testing shows no blockages in the coronary arteries. Management focuses on supportive care with medications until the heart muscle regains its normal function within weeks. Prognosis is generally good, though heart failure can occur in some cases.
Tako-Tsubo cardiomyopathy, also known as broken heart syndrome, is a temporary heart condition brought on by sudden intense emotions or physical stress. It causes the left ventricle of the heart to balloon out at the bottom and not pump properly. The condition is usually triggered by surges of stress hormones like epinephrine and norepinephrine. While it resembles a heart attack, angiography shows no blockages in the coronary arteries. Symptoms include chest pain and shortness of breath. Treatment focuses on supporting heart function with medications until the heart recovers on its own, which usually occurs within weeks.
An acute myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow to the heart is blocked, injuring the heart muscle. Risk factors include previous cardiovascular disease, older age, smoking, high cholesterol, diabetes, high blood pressure, obesity, and chronic kidney disease. Treatment involves restoring blood flow through procedures like angioplasty or thrombolysis, along with medications like aspirin, nitroglycerin, and statins. Recovery involves cardiac rehabilitation with exercise training and lifestyle changes to manage risk factors and prevent future heart attacks.
The document discusses several topics related to health and medicine science news:
- A chaperone enzyme was identified as a new potential target for cancer treatments.
- A gene variant that protects some African Americans from coronary artery disease was discovered.
- The rest of the document provides background information on cancer, coronary heart disease, their causes and risk factors, and current medical treatments.
Lipoproteins are biochemical assemblies containing both lipids and proteins that enable fats like triglycerides and cholesterol to be transported around the body in the bloodstream. Examples include HDL and LDL lipoproteins. Atherosclerosis is a disease where plaque builds up in the arteries due to factors like high cholesterol, reducing blood flow and potentially leading to heart attack, stroke or other issues if left untreated. Treatments for atherosclerosis focus on lifestyle changes and medications to control risk factors and cholesterol levels, or procedures like angioplasty or endarterectomy in severe cases.
Coronary artery disease (CAD) occurs when the coronary arteries become narrowed or blocked, limiting blood flow to the heart. A seminar on CAD covered its definition, causes like smoking and high cholesterol, symptoms like chest pain, diagnostic tests, and management. CAD develops over many years as plaques build up in the arteries. It is the most common cause of death globally.
This document summarizes research on vitamin D deficiency and cardiovascular risks. It discusses how vitamin D metabolism and mechanisms of action may impact cardiovascular outcomes. Several studies are cited showing associations between vitamin D deficiency and increased risks of hypertension, diabetes, heart disease, and mortality. However, the document also notes controversies in the research and calls for more rigorous randomized controlled trials. It outlines objectives and methods for a study examining vitamin D levels in patients with ischemic heart disease. The conclusion is that vitamin D levels correlate with cardiovascular disease and supplementation may help outcomes, but more clinical trials are still needed.
A 70-year-old female with a long history of uncontrolled hypertension was admitted for acute heart failure. On examination, she was in severe respiratory distress and orthopnea. Imaging showed severe calcified coarctation of the aorta, bicuspid aortic valve with severe stenosis, and significant coronary artery disease. An interventional cardiology team decided to perform a two-stage endovascular procedure to repair the cardiac and vascular issues due to her multiple comorbidities.
Potassium is a mineral important for many bodily functions like muscle contractions and regulating heartbeat. It is found in foods like fruits, vegetables, nuts, and whole grains. A potassium deficiency can cause muscle cramps, congestive heart failure, diarrhea, and other conditions. It is important to get adequate potassium through diet or supplements.
This document discusses cardiovascular drugs and their uses. It begins by defining cardiovascular drugs as those that act on the heart or blood vessels. It then describes the anatomy of the heart including the myocardium, conduction system, and nerve supply. It lists some common cardiovascular conditions treated by drugs such as congestive heart failure, angina pectoris, cardiac arrhythmias, and hypertension. For each condition, it provides details on symptoms, types, and mechanisms of treatment with drugs. It also discusses the mechanisms of several classes of cardiovascular drugs including cardiac glycosides, calcium channel blockers, beta blockers, and others.
Systemic lupus erythematosus (SLE) can involve all layers of the heart, including the pericardium, myocardium, valves, and coronary arteries. Patients with SLE have a 4-8 fold increased risk of developing cardiovascular disease compared to the general population. Studies have found significantly higher rates of atherosclerosis in SLE patients compared to age-matched controls, even in younger patients and those without traditional risk factors. Aggressive treatment of modifiable risk factors such as dyslipidemia, hypertension, and smoking is important for reducing cardiovascular risk in SLE patients.
Chelation therapy involves injecting or orally taking the synthetic amino acid EDTA, which binds to heavy metals like lead and calcium in the blood. This process releases hydrogen atoms that attach to arterial plaques, making the plaques soluble so they can be excreted in urine. As a result, arterial walls become softer and blood flow increases to organs. Some studies show chelation therapy may help unclog arteries and improve heart health, but more research is still needed due to potential side effects like hypocalcemia and zinc depletion.
The document discusses cardiovascular disease (CVD), which includes heart disease and stroke. CVD is the UK's number one killer. It occurs when fatty deposits build up in the arteries, restricting blood flow and oxygen to the heart and brain. A plant-based diet can help prevent and treat CVD in several ways. It is lower in saturated fat and cholesterol than the standard Western diet, and higher in nutrients that support heart health. Factors like high blood pressure, high cholesterol levels, obesity, and smoking increase CVD risk, but following a plant-based diet can help regulate these risk factors.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
2. Owen R. Fonorow Vitamin C and Heart Disease
heart patients were depleted of vitamin C. In 1953, Willis discovered that difference between beings that suffer heart disease and those that do not.
atherosclerotic plaques form over vitamin-C-starved vascular tissues in both (The first is the inability to make vitamin C.) Lp(a) has evolved in humans,
guinea pigs and human beings. Willis published several papers on this some primates, guinea pigs, some parrots and fruit bats to compensate for
subject that were peer-reviewed in the Canadian Medical Journal. His team the missing vitamin C, notably to patch cracked blood vessels.
also discovered that vitamin C can reverses the process of atherosclerosis in
both guinea pigs and humans. The majority of the population is not aware they have “chronic scurvy.”
As the condition progresses, the liver produces more Lp(a) molecules. A
Willis devised the first known method of photographing plaques with X- large number of Lp(a) molecules tend to deposit on top of existing plaque
rays. He observed that human plaques were not distributed uniformly formations. When the healing process overshoots, the arteries narrow and
throughout the vascular system. Instead, these "blockages" concentrate near the flow of blood is reduced. The first symptom may be a heart attack.
the heart, where arteries are constantly bent or squeezed. He reasoned that
only the mechanical stress, caused by the pulse, could explain the typical The Cure The Lp(a) molecules have a limited number of lysine binding
pattern of atherosclerosis in humans. The body was forming plaque sites - points of attachment to lysine. Pauling’s invention - the cure for
precisely where it was needed in order to stabilize the vascular system. heart disease - increases serum lysine high enough to make the Lp(a)
unattractive to any more lysine binding sites. As more lysine enters the
By the late 1980s, medical researchers discovered that heart disease begins blood stream, the probability increases that floating Lp(a) molecules will
with a lesion; lesions are cracks or stress fractures in the arterial wall. The bind with it (rather than with the patches of plaques growing on the
ensuing question became: What causes lesions in human beings since they arterial walls.)
do not arise naturally in most other animals?
Pauling and Rath's protocols for destroying existing atherosclerotic plaques
Then a variant of the so-called "bad" LDL cholesterol called lipoprotein(a), relies on more than fifty years of scientific research. Pauling filmed a
or Lp(a), was studied and found to be really sticky. The stickiness is caused video lecture in which he summarizes this research, and where he
by points of attachment on the surface of the Lp(a) molecule called lysine recommended that heart patients take the amino acid lysine daily in high
binding sites. Studies that led to the 1987 Nobel prize in medicine revealed amounts with their vitamin C. Neither vitamin C nor lysine have any
that lysine (and later proline) binding sites on the Lp(a) molecule cause known lethal dose.
atherosclerosis. Following that, Beisiegel et. al. in Germany examined
human atherosclerotic plaques post mortem and found only Lp(a) In his one hour video lecture, Pauling recounts the first cases in which his
cholesterol, not ordinary LDL cholesterol, as expected. (Prior to Beisiegel, high lysine therapy added to high vitamin C quickly resolved advanced
studies grouped Lp(a) together with LDL; both are low density cardiovascular disease in humans. Pauling doubted a clinical study was
lipoproteins.) even necessary before advising heart patients of the therapy because the
effect is so pronounced, and the binding inhibitors are nontoxic.
By 1989, Linus Pauling and his associate, Matthias Rath, had formulated and
published their unified theory of heart disease. Pauling/Rath theorized that Recently, in vitro test tube experiments have shown that the amino acid
the lack of vitamin C is the primary cause of heart disease in humans. Low proline may be an even more effective Lp(a) binding inhibitor than lysine.
vitamin C inevitably leads to atherosclerosis. They discovered that serum Consequently, adding between .5 and 2 g (500 mg to 2000 mg) proline
Lp(a) increases in response to the distress of vitamin C-starved tissues. may be of significant additional benefit.
Pauling and Rath had repeated the earlier Willis experiments with guinea Prevention Linus Pauling believed that chronic scurvy might be
pigs, but this time they monitored Lp(a). They discovered an inverse relation prevented with a daily intake of of vitamin C as low as 3000 mg. This
between vitamin C and Lp(a). Their theory holds that in most species, amount approximates what some animals synthesize under normal
vitamin C is plentiful and helps prevent arterial lesions. However, in a few conditions. Dr. Sydney Bush’s Cardioretinometry (microscopic pictures of
species, such as humans and guinea pigs, serum Lp(a) levels increase to the retina) suggests that some people require up to 10,000 mg daily for
compensate for chronic scurvy. Thus Lp(a) is the second major genetic prevention.
2 3
www.VitaminCFoundation.org